RBC Capital sets a new price target for Johnson & Johnson (NYSE:JNJ) at $209, indicating a potential increase of approximately 9.26%.The potential acquisition of Protagonist Therapeutics could significantly expand JNJ's pharmaceutical portfolio.FDA approval of Simponi for children with ulcerative colitis underscores JNJ's commitment to addressing unmet medical needs.Johnson & Johnson (NYSE: JNJ) is a well-established company known for its diverse range of products in the healthcare sector, including pharmac ...

Core Viewpoint - The company, Jingwei Huirun (300120), announced on September 12 that it plans to enter projects aligned with its strategic planning, including radio frequency, through investments and acquisitions [1] Group 1 - The company is actively seeking to expand its business into the radio frequency sector [1] - Future announcements regarding this strategic move will be made by the company [1]

编辑 岳彩周 校对 卢茜 新京报贝壳财经讯（记者张晓翀）7月31日，全国中小企业股份转让系统（俗称"新三板"）挂牌公司厦 门鑫点击网络集团股份有限公司发布公告称，全资子公司厦门深慧算信息科技有限公司拟出资设立全资 子公司厦门深度慧造制造有限公司、厦门智算创造制造有限公司、厦门图灵制造有限公司、深度慧造 （厦门）电子科技有限公司，4家公司注册资本均为人民币1000万元。 本次设立孙公司是公司战略发展的需要，有利于进一步扩大公司的业务范围，更好地布局优势资源，寻 找业务新的扩张点和收入增长点。 ...